November 11, 2014
9:30 am to 10:30 am EDT

Sponsored by

Webinar Description:

Medical treatments are becoming increasingly specialized, personalized, and targeted to specific therapies. The shift in drug portfolios has impacted not only the innovation landscape, but also the generic drug landscape and the active ingredient landscape. Understanding how these shifts will impact your business strategies, partnerships, and potential competition is critical for your company’s long term growth and success.

Learning Objectives:

• Understand the current market environment
• Identify trends emerging around the world
• Gain best practices implemented by other companies in response to current pressures
• Learn strategies for long term success

Speaker:

Molly Bowman

Thomson Reuters Senior Manager
Newport Content - Generics & API Intelligence

As Senior Manager of Newport Content - Generics & API Intelligence, Molly is responsible for overseeing the information contained in the Newport product suite. Newport's content team specializes in gathering competitive intelligence on the worldwide active ingredients market and global generic pharmaceutical sector. Prior to joining Thomson Reuters in 2007, Molly worked in the environmental field as a project coordinator and quality assurance officer. She holds a degree in chemistry from Smith College, and performed graduate studies at the SUNY College of Environmental Science and Forestry.

Cost: No cost!